Alexander Maass

Cardiologist

Alexander Maass has been trained in Würzburg/Germany as Internist, Cardiologist and Clinical Electrophysiologist. Since May 2006, dr. Maass works as Cardiologist and Director of the Cardiac Device Program in the University Medical Centre Groningen, The Netherlands. In 2016, he became Deputy Director of the Cardiology Training program and since September 2019, he is fully responsible for training young doctors to become cardiologists.

Current activities

His research focus is on optimization of cardiac device implantation and programming. He has participitated as an investigator in several landmark device studies and is member of the critical event committee of several ongoing landmark device studies. He is supervising students on several investigator-initiated studies to improve delivery of pacemakers and implantable cardioverter-defibrillators with the main focus on cardiac resynchronisation therapy.

My projects

RACE V

Reappraisal of Atrial Fibrillation: Interaction between hyperCoagulability, Electrical remodeling, and Vascular Destabilisation in the Progression of AF

read more

My publications

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.

Heart failure with preserved ejection fraction and AF are very common diseases that also often occur in combination, further aggravating each other. Senile amyloidosis, either due to TTR (ATTRwt) or ANP (IAA) appears to play an important role in both diseases and in their interaction. In terms of diagnostics, bone scintigraphy has become available and affords an easy and reliable way to establish the presence of cardiac ATTRwt. Moreover, pharmacological options are now available or under development to treat ATTRwt and possibly also IAA, thereby potentially stopping, or even reversing, the downhill course of some patients with HFpEF and AF.

view on Oxford Academic

QRS area is a strong determinant of outcome in cardiac resynchronization therapy.

Van Stipdonk AMW, ter Horst IAH, Kloosterman M, Engels EB, Rienstra M, Crijns HJGM, Vos MA, Van Gelder IC, Prinzen FW, Meine M, Maass AH, Vernooy K. Circ Arr Elec 2018; e006497

view on publisher site

Refining success of cardiac resynchronisation therapy using a simple score prediciting the amount of reverse ventricular remodeling: Results from the Markers And Response to CRT (MARC) study.

Maass AH, Vernooy K, Wijers SC, van ’t Sant J, Cramer MJ, Meine M, Allaart CP, de Lange FJ, Prinzen PW, Gerritse B, Erdtsiek E, Scheerder COS, Hill MRS, Scholten M, Kloosterman M, ter Horst IAH, Voors AA, Vos MA, Rienstra M, Van Gelder IC. Europace 2018

view on publisher site

Diagnostic imaging in infective endocarditis: a systematic literature review and proposal of an updated diagnostic work-up.

Gomes A, Glaudemans AW, Touw DJ, van Melle JP, Willems TP, Maass AH, Natour E, Prakken NH, Borra RJ, van Geel PP, Slart RH, van Assen S, Sinha B. Lancet Infect Dis 2017

view on publisher site

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, De Groot JR, Oostroom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knoops RE. J Am Coll Cardiol 2012

view on publisher site